Tim Jinks, Head of Drug - Resistant Infections at Wellcome, said: «E. coli are the leading
cause of bloodstream infections and this study helps illustrate the incredible complexity of the acquisition and spread of multidrug - resistant strains.
To investigate whether individuals treated with statins experienced a decreased
risk of bloodstream infection by S. aureus, researchers from the University Hospitals in Aalborg and Aarhus, Denmark and the University Hospital in Seville, Spain analyzed records of close to 30,000 people using Danish medical registries over a 12 - year period.
Figures show an increase in the
numbers of bloodstream infections caused by Staphylococcus aureus, including the strain of bacteria susceptible to Meticillin related antibiotics (MSSA).
To better understand the
types of bloodstream infections found in community hospitals, and the risk factors that lead to infection, Anderson and his colleagues collected information on patients seen at community hospitals in Virginia and North Carolina from 2003 to 2006.
«Our results indicate that statins may have an important place in the
prevention of bloodstream infection caused by S. aureus, which would hold important clinical and public health implications.
S. aureus was the most common pathogen, causing 28
percent of bloodstream infections, closely followed by E. coli, which was found in 24 percent of patients with infections.
Despite being a very common bacterium that is carried naturally in the human digestive tract, E. coli are also the leading
cause of bloodstream infections.
Candida albicans is a leading cause
of bloodstream infection and fungal sepsis, with a high mortality rate.